bf/NASDAQ:SPRC_icon.jpeg

NASDAQ:SPRC

SciSparc Ltd

  • Stock

USD

Last Close

2.67

06/11 22:05

Market Cap

1.65M

Beta: -

Volume Today

91.46K

Avg: 1.06M

PE Ratio

−6.39

PFCF: −0.69

OverviewFinancialsAPI

    Description

    SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The compan...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -40-30-20-102015-12-312016-11-232018-11-282019-12-312021-12-30

    Revenue (Estimate*)

    200K400K600K800K1M2015-12-312016-11-232018-11-282019-12-312021-12-30

    *Estimate based on analyst consensus